Invesco Ltd. Acquires 30,954 Shares of Oscar Health, Inc. $OSCR

Key Points

• Invesco Ltd. increased its stake in Oscar Health, Inc. by 14.5%, owning approximately 0.10% of the company valued at $3.21 million as of the latest SEC filing.
• Other institutional investors have also significantly raised their positions in Oscar Health, with some firms reporting increases of up to 83,733.3%.
• A majority of Wall Street analysts are bearish, with five analysts rating the stock as a "Sell" and a consensus price target set at $12.07.

Invesco Ltd. lifted its stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 14.5% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 244,980 shares of the company's stock after buying an additional 30,954 shares during the quarter. Invesco Ltd. owned approximately 0.10% of Oscar Health worth $3,212,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Larson Financial Group LLC lifted its holdings in shares of Oscar Health by 83,733.3% in the first quarter. Larson Financial Group LLC now owns 2,515 shares of the company's stock worth $33,000 after buying an additional 2,512 shares in the last quarter. CWM LLC lifted its holdings in shares of Oscar Health by 50.7% in the first quarter. CWM LLC now owns 3,204 shares of the company's stock worth $42,000 after buying an additional 1,078 shares in the last quarter. Princeton Global Asset Management LLC purchased a new position in shares of Oscar Health in the first quarter worth $59,000. GAMMA Investing LLC lifted its holdings in shares of Oscar Health by 2,156.4% in the first quarter. GAMMA Investing LLC now owns 6,476 shares of the company's stock worth $85,000 after buying an additional 6,189 shares in the last quarter. Finally, Tower Research Capital LLC TRC lifted its holdings in shares of Oscar Health by 171.4% in the fourth quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company's stock worth $89,000 after buying an additional 4,185 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company's stock.

Oscar Health Trading Down 1.4%

OSCR stock traded down $0.23 during mid-day trading on Tuesday, reaching $16.44. 14,062,728 shares of the stock traded hands, compared to its average volume of 13,584,614. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.86 and a current ratio of 0.86. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.79. The stock has a market capitalization of $4.25 billion, a PE ratio of -20.29 and a beta of 1.87. The business has a 50-day moving average price of $15.95 and a two-hundred day moving average price of $14.92.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) EPS for the quarter, topping analysts' consensus estimates of ($0.90) by $0.01. The firm had revenue of $2.86 billion for the quarter, compared to analysts' expectations of $2.88 billion. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The business's revenue for the quarter was up 29.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.20 earnings per share. Equities research analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on OSCR. Piper Sandler reduced their price target on shares of Oscar Health from $14.00 to $13.00 and set a "neutral" rating on the stock in a research report on Thursday, August 14th. Raymond James Financial cut shares of Oscar Health from an "outperform" rating to a "market perform" rating in a research report on Tuesday, June 24th. Wall Street Zen cut shares of Oscar Health from a "hold" rating to a "sell" rating in a research report on Saturday, August 9th. Robert W. Baird restated a "neutral" rating and issued a $14.00 price target (down previously from $28.00) on shares of Oscar Health in a research report on Friday, July 25th. Finally, Barclays reduced their price target on shares of Oscar Health from $17.00 to $11.00 and set an "underweight" rating on the stock in a research report on Wednesday, July 23rd. Four investment analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of "Strong Sell" and a consensus price target of $12.07.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.